|
BCTX Briacell Therapeutics Corp 1610820 |
| Income Statement |
|
Net Income
|
form10-q
|
-5,802,175 |
| Balance Sheet |
|
Current Assets
|
8,219,095 |
|
Assets
|
10,414,330 |
|
Current Liabilities
|
4,988,636 |
|
Liabilities
|
6,701,315 |
|
Equity
|
3,713,015 |
|
Shares Out
|
30,710,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-6,955,076 |
|
Investing Cash Flow
|
-75,000 |
| Market Analysis |
Market Cap
|
19,968,629 |
|
Price
|
4.33 |
|
BVPS
|
0.12 |
|
PB
|
34.82 |
|
PS
|
3.15 |
|
FCF
|
-7,030,076 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BCTX documents filed with the SEC.
BCTX Filings
Clear
